Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.

https://psnet.ahrq.gov/issue/artificial-intelligence-supported-screen-reading-versus-standard-double-reading-mammography